---
title: "Urogen Pharma (URGN.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/URGN.US/norm.md"
symbol: "URGN.US"
name: "Urogen Pharma"
parent: "https://longbridge.com/en/quote/URGN.US.md"
datetime: "2026-03-13T21:19:16.729Z"
locales:
  - [en](https://longbridge.com/en/quote/URGN.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/URGN.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/URGN.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/URGN.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/URGN.US/norm.md)


# Urogen Pharma (URGN.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.5355 | -0.6939 | -1.05 | -0.9245 | -0.7976 |
| ROE | 95.49% | 127.78% | 285.71% | 634.70% | -1795.69% |
| Revenue | 37.84M | 27.48M | 24.21M | 20.25M | 24.57M |
| Net income | -26.36M | -33.35M | -49.94M | -43.84M | -37.51M |
| Operating income | -19.11M | -27.39M | -41.45M | -36.91M | -28.76M |
| Gross margin | 91.31% | 88.07% | 85.34% | 88.50% | 89.94% |
| Net margin | -69.68% | -121.34% | -206.24% | -216.47% | -152.71% |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 200.46M | 185.05M | 208.72M | 247.62M | 285.71M |
| Leverage | -1.90 | -1.60 | -2.24 | -5.33 | -32.46 |
| BVPS | -2.18 | -2.47 | -2.02 | -1.01 | -0.2084 |
| Turnover | 0.4516 | 0.3964 | 0.3842 | 0.4100 | 0.3896 |
| Cash & STI | 120.46M | 127.03M | 156.95M | 195.89M | 236.69M |
| Inv & Rec | 16.46M | 8.34M | 7.13M | 7.59M | 9.23M |
| LT assets | 9.09M | 9.18M | 6.24M | 5.38M | 3.79M |
| Net debt | 9.63M | 2.53M | -34.12M | -74.04M | -116.79M |

## Cash Flow Statement (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -38.33M | -42.27M | -39.83M | -42.02M | -13.62M |
| Investing CF | 27.72M | 31.40M | 28.41M | -25.96M | 60.62M |
| Financing CF | 31.32M | 8.27M | 296000.00 | 34000.00 | 71000.00 |
| Free CF | -28.20M | -20.48M | -15.93M | -25.22M | 4.05M |
| OCF coverage | -2047.28% | -48586.21% | -28244.68% | -95509.09% | -11842.61% |
| Repaid & issued | - | - | - | - | 0.0000 |
| CapEx | -17000.00 | -87000.00 | -141000.00 | -44000.00 | -115000.00 |